SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-028409
Filing Date
2014-05-08
Accepted
2014-05-08 08:14:19
Documents
6
Period of Report
2014-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v377857_8k.htm 8-K 40666
2 EXHIBIT 2.1 v377857_ex2-1.htm EX-2.1 664950
3 EXHIBIT 2.2 v377857_ex2-2.htm EX-2.2 104737
4 EXHIBIT 99.1 v377857_ex99-1.htm EX-99.1 69932
5 GRAPHIC image_002.jpg GRAPHIC 13946
6 GRAPHIC image_001.jpg GRAPHIC 11695
  Complete submission text file 0001144204-14-028409.txt   917106
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 14823083
SIC: 2836 Biological Products, (No Diagnostic Substances)